Clinical characteristics and long-term outcomes in patients with peripartum cardiomyopathy (PPCM) receiving left ventricular assist devices (LVAD).
Dominik BerlinerTong LiSilvia MarianiRighab HamdanJasmin Sarah HankeTobias KönigTobias Jonathan PfefferValeska Abou-MouligGuenes DoganDenise Hilfiker-KleinerAxel HaverichJohann BauersachsJan D SchmittoPublished in: Artificial organs (2022)
LVAD treatment of decompensated end-stage PPCM is feasible. Early LVAD provision led to hemodynamic stabilization in our cohort and facilitated safe LV recovery in one third of these young female patients.
Keyphrases
- heart failure
- ejection fraction
- left ventricular
- end stage renal disease
- left ventricular assist device
- newly diagnosed
- chronic kidney disease
- prognostic factors
- aortic stenosis
- peritoneal dialysis
- palliative care
- hypertrophic cardiomyopathy
- patient reported outcomes
- cardiac resynchronization therapy
- percutaneous coronary intervention
- acute coronary syndrome
- combination therapy
- replacement therapy
- smoking cessation